DEUTSCHE BANK AG\ - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 100 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$12,336,144
-71.7%
324,294
-32.2%
0.01%
-65.2%
Q2 2023$43,579,142
+10.2%
478,366
-20.2%
0.02%
+4.5%
Q1 2023$39,538,271
+190.5%
599,428
+127.8%
0.02%
+175.0%
Q4 2022$13,608,883
-64.9%
263,177
-53.6%
0.01%
-65.2%
Q3 2022$38,776,000
+23.5%
567,745
-18.3%
0.02%
+27.8%
Q2 2022$31,410,000
+13.6%
694,607
+27.6%
0.02%
+38.5%
Q1 2022$27,657,000
+72.7%
544,311
+60.7%
0.01%
+85.7%
Q4 2021$16,015,000
+67.0%
338,753
+16.4%
0.01%
+40.0%
Q3 2021$9,591,000
-52.6%
291,009
-9.0%
0.01%
-50.0%
Q2 2021$20,221,000
+12.3%
319,961
-23.8%
0.01%0.0%
Q1 2021$18,007,000
-50.3%
419,660
-33.8%
0.01%
-54.5%
Q4 2020$36,250,000
+115.6%
633,737
+13.7%
0.02%
+83.3%
Q3 2020$16,812,000
-5.6%
557,231
+2.2%
0.01%
-14.3%
Q2 2020$17,803,000
+258.4%
545,087
+193.9%
0.01%
+250.0%
Q1 2020$4,968,000
-1.6%
185,442
+12.4%
0.00%
+33.3%
Q4 2019$5,050,000
+60.4%
165,010
+26.2%
0.00%
+50.0%
Q3 2019$3,148,000
+8.7%
130,763
+14.3%
0.00%0.0%
Q2 2019$2,896,000
+16.5%
114,364
-10.3%
0.00%
+100.0%
Q1 2019$2,485,000
+624.5%
127,516
+388.8%
0.00%
Q4 2018$343,000
-90.2%
26,085
-86.8%
0.00%
-100.0%
Q3 2018$3,516,000
+25.5%
197,857
+55.3%
0.00%0.0%
Q2 2018$2,802,000
+783.9%
127,397
+785.7%
0.00%
Q1 2018$317,000
-38.6%
14,384
-39.6%
0.00%
Q4 2017$516,00023,8080.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 2,503,059$170,959,00029.50%
ACUTA CAPITAL PARTNERS, LLC 554,000$37,838,00016.29%
Avoro Capital Advisors LLC 10,125,000$691,538,00012.78%
Sio Capital Management, LLC 507,700$34,676,00011.02%
Logos Global Management LP 1,300,000$88,790,00010.92%
EcoR1 Capital, LLC 5,183,431$354,028,00010.45%
Cormorant Asset Management, LP 1,478,000$100,947,0007.06%
Finepoint Capital LP 266,090$18,174,0005.98%
Ghost Tree Capital, LLC 275,000$18,783,0005.27%
Boxer Capital, LLC 1,303,700$89,043,0005.01%
View complete list of APELLIS PHARMACEUTICALS INC shareholders